Skip to main content
Nanobiotix S.A. logo

Nanobiotix S.A. — Investor Relations & Filings

Ticker · NBTX US Manufacturing
Open in API
Filings indexed 292 across all filing types
Latest filing 2026-06-08 Share Issue/Capital Cha…
Country US United States of America
Listing US NBTX

About Nanobiotix S.A.

https://www.nanobiotix.com

Nanobiotix S.A. is a late-stage clinical biotechnology company that pioneers the development of physics-based nanotherapeutics. The company's lead candidate, NBTXR3, is a potential first-in-class radioenhancer designed to be injected directly into a tumor. It works by amplifying the dose of radiotherapy absorbed by cancer cells without increasing the dose in surrounding healthy tissues. This localized destruction also aims to prime an immune response to attack metastatic tumors. Nanobiotix is engaged in a global licensing agreement with Janssen Pharmaceutica NV, a Johnson & Johnson company, for the co-development and commercialization of NBTXR3. The initial development focus is on solid tumors, particularly in head, neck, and lung cancers, for patient populations with limited treatment options.

Recent filings

Filing Released Lang Actions
S-8
Share Issue/Capital Change Classification · 95% confidence The document is an SEC Form S-8 Registration Statement filed under the Securities Act of 1933 to register shares under the 2026 Free Share Plan. Form S-8 is used to register new equity securities for employee benefit plans, representing a forthcoming issuance of shares and a capital change. This aligns with the “Share Issue/Capital Change” category (SHA).
2026-06-08 English
FORM 6-K
Regulatory Filings Classification · 85% confidence The document is a U.S. SEC Form 6-K submitted by Nanobiotix S.A., a foreign private issuer, to furnish a press release (Exhibit 99.1) under Rule 13a-16/15d-16. Form 6-K filings are miscellaneous regulatory submissions by foreign issuers and do not themselves contain full financial statements or detailed report content. This fits the definition of a Regulatory Filing (RNS) as a general compliance/regulatory announcement rather than a standalone earnings release, annual report, or other specific category.
2026-06-05 English
FORM 6-K
Regulatory Filings Classification · 85% confidence The document is a U.S. SEC Form 6-K filed by a foreign private issuer to furnish a press release under the Exchange Act. It does not contain financial statements itself or constitute an annual or interim report; rather, it is a regulatory compliance filing for a press release. It therefore falls under the general Regulatory Filings category (RNS).
2026-06-02 English
FORM 6-K
Regulatory Filings Classification · 90% confidence The document is an SEC Form 6-K filed by a foreign private issuer pursuant to the Exchange Act. It simply attaches a press release as Exhibit 99.1 and contains no substantive financial statements or detailed report content. Under the classification rules, this is a miscellaneous regulatory filing (RNS), not a full report, earnings release, or other specific category.
2026-06-02 English
FORM 6-K
Share Issue/Capital Change Classification · 82% confidence The document is a Form 6-K reporting the closing of a global offering of ADSs, ordinary shares and pre-funded warrants pursuant to an underwriting agreement. It details the terms of the share issuance and related capital change. This is an equity financing transaction announcement, i.e. a new share issue. Therefore, the correct classification is Share Issue/Capital Change (SHA).
2026-05-26 English
FORM 6-K
Regulatory Filings Classification · 90% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer to furnish a press release (Exhibit 99.1). It does not contain intrinsic financial statements or constitute an annual/interim report, nor is it a specific event notice like management changes or dividends. It is therefore a regulatory submission that falls under the general Regulatory Filings category (RNS).
2026-05-26 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.